XXII on Nasdaq
22nd Century Group, Inc.
American cigarettes company that raised $98.4 million in 2024 (SEC Form D)2
In its 2026 annual report the company says: “22nd Century Group, Inc. is a tobacco products company that enables cigarette smokers to take control of their consumption of nicotine, the addictive drug in cigarettes. We manufacture and distribute the only combustible tobacco products containing minimally or non-addictive levels of nicotine that are authorized by the US Food and Drug Administration (FDA) for retail purchase. We also provide turnkey contract manufacturing of cigarettes and filtered cigars for other established tobacco brands.”5 It is headquartered in Carson City, United States.2 Its shares trade on Nasdaq under the symbol XXII.2
Price unavailable
Last updated Oct 21, 2026.
Overview
Compare with Ispire Technology Inc., RLX Technology Inc. or Altria, or pick any stock.
- TickerXXII on Nasdaq2
- IndustryCigarettes2
- HeadquartersCarson City, United States2
- Incorporated inFL3
- Business address8560 Main Street, Suite 4, Williamsville, In 142213
- Filer categoryNon-accelerated filer, Smaller reporting company3
- Legal formCorporation2
- LEI5493000LGPXTLG1UMJ562
- StatusActive2
- LEI statusLapsed (not renewed)2
- Registered address112 NORTH CURRY STREET, 89703 Carson City, United States2
- Registered withBusiness Center (Secretary of State), E0607512005-32
See how the biggest companies compare on our leaderboards
22nd Century Group, Inc. is a tobacco products company that enables cigarette smokers to take control of their consumption of nicotine, the addictive drug in cigarettes. We manufacture and distribute the only combustible tobacco products containing minimally or non-addictive levels of nicotine that are authorized by the US Food and Drug Administration (FDA) for retail purchase. We also provide turnkey contract manufacturing of cigarettes and filtered cigars for other established tobacco brands.5 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Cigarettes brought in 73% of the revenue 22nd Century Group, Inc. broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2024 | 2025 |
|---|---|---|
| Cigarettes | $14.2M | $12.9M |
| Filtered Cigars | $9.4M | $4.1M |
| Other Tobacco Products | $756.0K | $442.0K |
| VLN | -$20.0K | $138.0K |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue55¢$10.2M
- Research and development4¢$688.0K
- Selling, general and admin41¢$7.6M
- Income tax0¢$28.0K
Out of $17.6M in revenue.6 The company lost money this year.
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.6
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenues, net | $17.6M | $24.4M |
| Cost of goods sold | $10.2M | $14.3M |
| Excise taxes and fees on products | $10.5M | $12.5M |
| Gross loss | -$3.1M | -$2.4M |
| Sales, general and administrative | $7.6M | $10.3M |
| Research and development | $688.0K | $1.1M |
| Other operating expense, net | $150.0K | $130.0K |
| Total operating expenses | $8.4M | $11.6M |
| Operating loss from continuing operations | -$11.6M | -$13.9M |
| Other income (expense), net | -$207.0K | $507.0K |
| Interest income | $83.0K | $72.0K |
| Interest expense | -$1.5M | -$2.1M |
| Total other income (expense), net | -$1.6M | -$1.5M |
| Loss from continuing operations before income taxes | -$13.1M | -$15.5M |
| (Benefit) provision for income taxes | -$28.0K | $30.0K |
| Net loss from continuing operations | -$13.1M | -$15.5M |
| Income from discontinued operations before income taxes | $8.1M | $331.0K |
| Income from discontinued operations | $8.1M | $331.0K |
| Net loss | -$5.1M | -$15.2M |
| Comprehensive loss | -$5.1M | -$15.2M |
| Deemed dividends | -$4.7M | -$10.3M |
| Net loss available to common shareholders | -$9.7M | -$25.5M |
| Basic loss per common share from continuing operations (in dollars per share) | -$71 | -$27.8K |
| Basic income per common share from discontinued operations (in dollars per share) | $44 | $595 |
| Basic loss per common share from deemed dividends (in dollars per share) | -$25.42 | -$18,493.32 |
| Basic loss per common share (in dollars per share) | -$52.87 | -$45,711.05 |
| Diluted loss per common share from continuing operations (in dollars per share) | -$71 | -$27.8K |
| Diluted income per common share from discontinued operations (in dollars per share) | $44 | $595 |
| Diluted loss per common share from deemed dividends (in dollars per share) | -$25.42 | -$18,493.32 |
| Diluted loss per common share (in dollars per share) | -$52.87 | -$45,711.05 |
| Weighted average shares outstanding - basic (in shares) | 184.1K shares | 557 shares |
| Weighted average shares outstanding - diluted (in shares) | 184.1K shares | 557 shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.6
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $7.1M | $4.4M | |
| Accounts receivable, net | $3.6M | $1.7M | |
| Inventories | $4.3M | $2.0M | |
| Insurance recoveries | $768.0K | ||
| GVB promissory note, net | $500.0K | ||
| Prepaid expenses and other current assets | $2.6M | $1.1M | |
| Current assets of discontinued operations held for sale | $0 | $1.1M | |
| Total current assets | $17.6M | $11.5M | |
| Property, plant and equipment, net | $2.4M | $2.8M | |
| Operating lease right-of-use assets, net | $728.0K | $1.6M | |
| Intangible assets, net | $6.2M | $5.7M | |
| Other assets | $15.0K | ||
| Total assets | $27.0M | $21.7M | |
| Notes and loans payable-current | $204.0K | $254.0K | |
| Current portion of long-term debt | $1.5M | ||
| Operating lease obligations | $168.0K | $261.0K | |
| Accounts payable | $1.0M | $2.4M | |
| Accrued expenses and other current liabilities | $836.0K | $1.4M | |
| Accrued litigation | $768.0K | ||
| Accrued excise taxes and fees | $3.3M | $2.0M | |
| Contract liabilities | $1.7M | $20.0K | |
| Current liabilities of discontinued operations held for sale | $1.3M | ||
| Total current liabilities | $7.3M | $10.0M | |
| Notes and loans payable | $504.0K | ||
| Operating lease obligations | $601.0K | $1.4M | |
| Long-term debt | $5.2M | ||
| Other long-term liabilities | $154.0K | $1.1M | |
| Total liabilities | $8.5M | $17.7M | |
| Series A convertible preferred shares, $0.00001 par value; 10,000,000 shares authorized, 9,650 shares issued and outstanding at December 31, 2025 and 0 at December 31, 2024, respectively | $2.7M | ||
| Capital in excess of par value | $414.7M | $397.9M | |
| Accumulated deficit | -$398.9M | -$393.9M | |
| Total shareholders' equity | $15.8M | $4.0M | -$8.4M |
| Total liabilities, mezzanine equity and shareholders' equity | $27.0M | $21.7M | |
| Series A convertible preferred shares, par value (in dollars per share) | $0.00 | $0.00 | |
| Series A convertible preferred shares, shares authorized | 10.0M shares | 10.0M shares | |
| Series A convertible preferred shares, shares issued | 9.7K shares | 0 shares | |
| Series A convertible preferred shares, shares outstanding | 9.7K shares | 0 shares | |
| Common stock, par value (in dollars per share) | $0.00 | $0.00 | |
| Common stock, shares authorized | 500.0M shares | 500.0M shares | |
| Common stock, shares issued | 510.4K shares | 2.3K shares | |
| Common stock, shares outstanding | 510.4K shares | 2.3K shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $7.1M | $4.4M | |
| Accounts receivable, net | $3.6M | $1.7M | |
| Inventories | $4.3M | $2.0M | |
| Insurance recoveries | $768.0K | ||
| GVB promissory note, net | $500.0K | ||
| Prepaid expenses and other current assets | $2.6M | $1.1M | |
| Current assets of discontinued operations held for sale | $0 | $1.1M | |
| Total current assets | $17.6M | $11.5M | |
| Property, plant and equipment, net | $2.4M | $2.8M | |
| Operating lease right-of-use assets, net | $728.0K | $1.6M | |
| Intangible assets, net | $6.2M | $5.7M | |
| Other assets | $15.0K | ||
| Total assets | $27.0M | $21.7M | |
| Notes and loans payable-current | $204.0K | $254.0K | |
| Current portion of long-term debt | $1.5M | ||
| Operating lease obligations | $168.0K | $261.0K | |
| Accounts payable | $1.0M | $2.4M | |
| Accrued expenses and other current liabilities | $836.0K | $1.4M | |
| Accrued litigation | $768.0K | ||
| Accrued excise taxes and fees | $3.3M | $2.0M | |
| Contract liabilities | $1.7M | $20.0K | |
| Current liabilities of discontinued operations held for sale | $1.3M | ||
| Total current liabilities | $7.3M | $10.0M | |
| Notes and loans payable | $504.0K | ||
| Operating lease obligations | $601.0K | $1.4M | |
| Long-term debt | $5.2M | ||
| Other long-term liabilities | $154.0K | $1.1M | |
| Total liabilities | $8.5M | $17.7M | |
| Series A convertible preferred shares, $0.00001 par value; 10,000,000 shares authorized, 9,650 shares issued and outstanding at December 31, 2025 and 0 at December 31, 2024, respectively | $2.7M | ||
| Capital in excess of par value | $414.7M | $397.9M | |
| Accumulated deficit | -$398.9M | -$393.9M | |
| Total shareholders' equity | $15.8M | $4.0M | -$8.4M |
| Total liabilities, mezzanine equity and shareholders' equity | $27.0M | $21.7M | |
| Series A convertible preferred shares, par value (in dollars per share) | $0.00 | $0.00 | |
| Series A convertible preferred shares, shares authorized | 10.0M shares | 10.0M shares | |
| Series A convertible preferred shares, shares issued | 9.7K shares | 0 shares | |
| Series A convertible preferred shares, shares outstanding | 9.7K shares | 0 shares | |
| Common stock, par value (in dollars per share) | $0.00 | $0.00 | |
| Common stock, shares authorized | 500.0M shares | 500.0M shares | |
| Common stock, shares issued | 510.4K shares | 2.3K shares | |
| Common stock, shares outstanding | 510.4K shares | 2.3K shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.6
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net loss | -$5.1M | -$15.2M |
| Impairment of long-lived assets - held for sale | $293.0K | |
| Impairment of long-lived assets | $150.0K | $68.0K |
| Amortization and depreciation | $912.0K | $1.0M |
| Amortization of right-of-use assets | $245.0K | $255.0K |
| Other non-cash gains | -$32.0K | -$947.0K |
| Provision for credit losses | $388.0K | $1.0K |
| (Gain) loss on sale or disposal of property, plant, and equipment | -$12.0K | $127.0K |
| Debt related charges included in interest expense | $1.6M | $2.2M |
| Equity-based compensation | $421.0K | $380.0K |
| Change in fair value of warrant liabilities | $207.0K | -$492.0K |
| Change in fair value of derivative liability | -$556.0K | |
| Deferred income taxes | $7.0K | $8.0K |
| Change in inventory reserves | -$261.0K | -$4.4M |
| Accounts receivable | -$1.9M | -$30.0K |
| Inventories | -$2.0M | $6.7M |
| Prepaid expenses and other assets | -$1.4M | $159.0K |
| Accounts payable | -$2.7M | -$1.2M |
| Accrued expenses and other current liabilities | -$253.0K | -$2.6M |
| Accrued excise taxes and fees | $1.3M | -$196.0K |
| Contract liabilities | $1.7M | -$714.0K |
| Other liabilities | -$1.4M | $981.0K |
| Net cash used in operating activities | -$7.7M | -$14.3M |
| Acquisition of patents, trademarks, and licenses | -$814.0K | -$20.0K |
| Acquisition of property, plant and equipment | -$61.0K | -$141.0K |
| Proceeds from the sale of property, plant and equipment | $770.0K | $22.0K |
| Issuance of 2025 GVB promissory note | -$500.0K | |
| Payments received from 2025 GVB promissory note | $100.0K | |
| Net cash used in investing activities | -$505.0K | -$139.0K |
| Payments on notes payable | -$1.2M | -$1.5M |
| Proceeds from issuance of notes payable | $1.7M | $1.3M |
| Payments of penalties from long-term debt | -$28.0K | |
| Payments of long-term debt | -$4.3M | -$1.3M |
| Net proceeds from warrant exercise | $5.1M | $3.4M |
| Net proceeds from Series A convertible preferred stock | $9.9M | |
| Payments of deferred offering costs | -$130.0K | |
| Proceeds from issuance of common stock | $16.1M | |
| Payment of common stock issuance costs | -$1.0M | |
| Taxes paid related to net share settlement of RSUs | -$1.0K | |
| Net cash provided by financing activities | $11.0M | $16.8M |
| Net increase in cash and cash equivalents | $2.7M | $2.4M |
| Cash paid during the period for interest | $241.0K | $722.0K |
| Cash (received) paid during the period for income taxes | -$35.0K | $22.0K |
| Capital expenditures incurred but not yet paid | $45.0K | $43.0K |
| Deemed dividends | $4.7M | $10.3M |
| Stock issued in connection with settled indebtedness | $500.0K | $1.6M |
| Non-cash licensing arrangement | $309.0K | $250.0K |
| Right-of-use assets and corresponding operating lease obligations | -$666.0K | |
| Stock issued for extinguishment of Subordinated Note | $3.9M | |
| Payment of 2023 GVB promissory note | $500.0K | $1.5M |
| Payment of debt issuance costs | $603.0K | |
| Equity conversion of Senior Secured Credit Facility | $3.1M | $3.1M |
| Conversion option remeasurement | $283.0K |
No quarter-by-quarter statement was filed.
Corporate structure
22nd Century Group, Inc. sits at the top of its group. 13 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of 22nd Century Group, Inc.
- Iroquois Capital Management, LLC Filed SCHEDULE 13G on 22nd Century Group, Inc., latest Aug 25, 2026 (4 filings since Oct 23, 2024)
- Jonathan Schechter Filed SCHEDULE 13G on 22nd Century Group, Inc., latest Aug 20, 2026 (3 filings since May 28, 2025)
- Joseph Reda Filed SCHEDULE 13G on 22nd Century Group, Inc., latest Aug 20, 2026 (9 filings since Apr 12, 2024)
- Anson Funds Management LP Filed SCHEDULE 13G/A on 22nd Century Group, Inc., latest Aug 14, 2026 (7 filings since Feb 14, 2024)
- Gregory Castaldo Filed SCHEDULE 13G/A on 22nd Century Group, Inc., latest Feb 13, 2026 (4 filings since Oct 9, 2024)
- BlackRock Filed SC 13G/A on 22nd Century Group, Inc., latest Aug 9, 2022 (2 filings since Feb 4, 2022)
- ETF MANAGERS GROUP, LLC Filed SC 13G/A on 22nd Century Group, Inc., latest May 13, 2022 (2 filings since Dec 22, 2021)
- Empery Asset Management, LP Filed SC 13G/A on 22nd Century Group, Inc., latest Jan 13, 2022
- 22nd Century Group, Inc. Carson City, Nevada, United States
- 22nd Century Group Canada, Inc. Subsidiary · Canada
- 22nd Century Holdings, LLC Subsidiary · Delaware, United States
- 22nd Century Limited, LLC Subsidiary · Delaware, United States
- Botanical Genetics, LLC Subsidiary · Delaware, United States
- BridgeWay Distribution, LLC Subsidiary · Nevada, United States
- ESI Holdings, LLC Subsidiary · Nevada, United States
- Golden Acquisition Sub, LLC Subsidiary · Delaware, United States
- Goodrich Tobacco Company, LLC Subsidiary · Delaware, United States
- Heracles Pharmaceuticals, LLC Subsidiary · Delaware, United States
- Nasco Exports, LLC Subsidiary · Nevada, United States
- NASCO Products, LLC Subsidiary · North Carolina, United States
- PTB Investment Holdings, LLC Subsidiary · Nevada, United States
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What 22nd Century Group, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $7.8M6 Dec 31, 2025 | $7.5M6 Dec 31, 2024 | +3.8% |
| Accumulated depreciation | $5.4M6 Dec 31, 2025 | $4.8M6 Dec 31, 2024 | +13.1% |
| Property and equipment, net | $2.4M6 Dec 31, 2025 | $2.8M6 Dec 31, 2024 | −12.0% |
| Operating-lease assets (leased space) | $728.0K6 Dec 31, 2025 | $1.6M6 Dec 31, 2024 | −55.6% |
Investments
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Intangible assets, net (excluding goodwill) | $6.2M6 Dec 31, 2025 | $5.7M6 Dec 31, 2024 | +8.7% |
| Indefinite-lived intangibles (excluding goodwill) | $2.7M6 Dec 31, 2025 | $2.7M6 Dec 31, 2024 | −1.2% |
| Finite-lived intangibles, gross | $8.3M6 Dec 31, 2025 | $7.4M6 Dec 31, 2024 | +12.9% |
| Accumulated amortization | $4.6M6 Dec 31, 2025 | $4.3M6 Dec 31, 2024 | +8.9% |
| Finite-lived intangibles, net | $3.6M6 Dec 31, 2025 | $3.0M6 Dec 31, 2024 | +17.6% |
Inventory
| Item | Latest | A year before | Change |
|---|---|---|---|
| Inventory, total | $4.3M6 Dec 31, 2025 | $2.0M6 Dec 31, 2024 | +114.7% |
| Raw materials | $4.2M6 Dec 31, 2025 | $1.6M6 Dec 31, 2024 | +160.7% |
| Work in process | $011 Dec 31, 2024 | $3.0K9 Dec 31, 2022 | −100.0% |
| Finished goods | $113.0K6 Dec 31, 2025 | $399.0K6 Dec 31, 2024 | −71.7% |
Properties, in its own words
As of December 31, 2025, we operated two tobacco facilities located in Mocksville, North Carolina and surrounding areas. These locations are comprised of one leased manufacturing facility (which is also our principal executive office and headquarters) and one leased inventory storage facility. We believe the facilities we operate and their equipment are effectively utilized, well maintained, generally are in good condition, and will be able to accommodate our capacity needs to meet current and growing levels of demand.
Item 2 of the 10-K filed Mar 26, 2026.5
Leadership
Who has led 22nd Century Group, Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
Chief operating officer
- Chief executive officerLawrence Firestone Dec 8, 2023 to now15
- Chief executive officerJames A. Mish Jun 23, 2020 to Mar 21, 202316
- Chief executive officerClifford B. Fleet Aug 9, 2019 to Sep 11, 201917
- Chief executive officerHenry Sicignano Iii. Jan 27, 2016 to Apr 3, 201818
- Chief executive officerJoseph Pandolfino Feb 4, 2011 to Mar 12, 201419
- Chief executive officerNanuk Warman Sep 22, 2010 to Sep 22, 201020
- Chief executive officerRonald Asirwatham Nov 29, 2010 to Nov 29, 201021
- PresidentClifford B. Fleet Aug 9, 2019 to Sep 11, 201917
- PresidentMichael Zercher Dec 17, 2019 to Sep 2, 202222
- PresidentHenry Sicignano Iii. Feb 4, 2011 to Apr 3, 201823
- PresidentNanuk Warman Sep 22, 2010 to Sep 22, 201020
- Chief financial officerDaniel A. Otto Apr 29, 2024 to now24
- Chief financial officerRobert Hugh Kinsman Aug 3, 2022 to Mar 16, 202325
- Chief financial officerRichard F. Fitzgerald Nov 19, 2021 to Mar 23, 202226
- Chief financial officerJohn Franzino Jun 5, 2020 to Jun 10, 202127
- Chief financial officerAndrea S. Jentsch Dec 4, 2019 to Mar 16, 202028
- Chief financial officerJohn T. Brodfuehrer Apr 2, 2013 to Mar 4, 201929
- Chief financial officerHenry Sicignano Iii. Nov 14, 2012 to Jan 28, 201430
- Chief financial officerCharles Anthony Rider Feb 4, 2011 to May 21, 201231
- Chief financial officerNanuk Warman Sep 22, 2010 to Sep 22, 201020
- Chief financial officerRonald Asirwatham Nov 29, 2010 to Nov 29, 201021
- Chief operating officerMichael Zercher Jun 19, 2019 to Sep 2, 202232
- Chief operating officerHenry Sicignano Iii. Feb 18, 2015 to Feb 18, 201533
Board members and other officers (27)
- EVP of Sales and MarketingRobert P. Manfredonia Sep 16, 2024 to now34
- VP of Mfg. OperationsArvil S. Marion Oct 10, 2024 to now35
- Chief Administrative OfficerJohn Franzino Mar 23, 2022 to Mar 21, 202336
- Senior VP-Science & RegulatoryJames E. Swauger Nov 8, 2017 to Nov 8, 201737
- VP of Plant BiotechnologyPaul Rushton Oct 9, 2015 to May 26, 201738
- VICE PRESIDENT OF R&DMichael Robert Moynihan Feb 4, 2011 to Sep 29, 201739
- Board memberDavid N. Keys Aug 5, 2025 to now40
- Board memberJames A. Mish Feb 10, 2023 to Mar 21, 202341
- Board memberAndrew Arno Jul 27, 2023 to now42
- Board memberLawrence Firestone Dec 8, 2023 to now15
- Board memberLucille S. Salhany Sep 12, 2022 to now43
- Board memberAnthony L. Johnson Aug 26, 2021 to now44
- Board memberRoger D. O'Brien Jan 16, 2020 to Mar 23, 202245
- Board memberMichael Koganov Sep 22, 2020 to Mar 16, 202346
- Board memberClifford B. Fleet Aug 9, 2019 to Mar 23, 202217
- Board memberNora B. Sullivan May 22, 2015 to Mar 16, 202347
- Board memberRichard M. Sanders Dec 19, 2013 to Mar 16, 202348
- Board memberJoseph Pandolfino Feb 4, 2011 to Jun 30, 201519
- Board memberHenry Sicignano Iii. Jun 8, 2011 to Apr 3, 201849
- Board memberJoseph A. Dunn Jun 9, 2011 to Mar 4, 201950
- Board memberJames W. Cornell Jun 14, 2011 to Sep 13, 201951
- Board memberSteven Katz Jun 23, 2011 to Jun 23, 201152
- Board memberNanuk Warman Sep 22, 2010 to Sep 22, 201020
- Board memberRonald Asirwatham Nov 29, 2010 to Nov 29, 201021
- General counselJonathan Staffeldt Apr 29, 2024 to now53
- General counselPeter Ferola Mar 3, 2023 to Mar 16, 202354
- General counselThomas L. James May 16, 2014 to Jun 19, 201955
Named in SEC Form D filings
People the company listed in its private-offering notices.
Subsidiaries and ownership
Subsidiaries (Exhibit 21)
- 22nd Century Group Canada, Inc. Canada4
- 22nd Century Holdings, LLC Delaware4
- 22nd Century Limited, LLC Delaware4
- Botanical Genetics, LLC Delaware4
- BridgeWay Distribution, LLC Nevada4
- ESI Holdings, LLC Nevada4
- Golden Acquisition Sub, LLC Delaware4
- Goodrich Tobacco Company, LLC Delaware4
- Heracles Pharmaceuticals, LLC Delaware4
- NASCO Products, LLC North Carolina4
- Nasco Exports, LLC Nevada4
- PTB Investment Holdings, LLC Nevada4
The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Former names
- Touchstone Mining LTDDec 27, 2005 to Nov 2, 20103
Timeline
- Sep 1, 20268-K Regulation FD disclosure59
- Aug 13, 20268-K Results of operations60
- Aug 5, 20268-K Shareholder vote61
- Jul 2, 20268-K Ended a material agreement62
- Jun 11, 20268-K Shareholder vote63
- Jun 9, 20268-K Entered a material agreement; Unregistered sale of shares; Change to shareholders' rights64
- Jun 9, 20268-K Entered a material agreement; Unregistered sale of shares; Change to shareholders' rights65
- May 7, 20268-K Results of operations66
- May 1, 20268-K Entered a material agreement67
- Mar 26, 20268-K Results of operations68
- Mar 20, 20268-K Entered a material agreement; Change to shareholders' rights; Bylaws or fiscal year changed69
- Feb 20, 20268-K Results of operations; Shareholder vote; Other events70
- Dec 8, 2023New chief executive Lawrence Firestone becomes CEO15
- Jun 23, 2020New chief executive James A. Mish becomes CEO16
- Aug 9, 2019New chief executive Clifford B. Fleet becomes CEO17
- Jan 27, 2016New chief executive Henry Sicignano Iii. becomes CEO18
- Feb 4, 2011New chief executive Joseph Pandolfino becomes CEO19
- Nov 29, 2010New chief executive Ronald Asirwatham becomes CEO21
- Sep 22, 2010New chief executive Nanuk Warman becomes CEO20
- Sep 11, 2005Founded 22nd Century Group, Inc. is founded2
Calendar
Coming up
- Nov 3, 2026Reports results for the quarter ending Sep/202671
When it reported results
- Aug 13, 2026Reported quarterly or annual results60
- May 7, 2026Reported quarterly or annual results66
- Mar 26, 2026Reported quarterly or annual results68
- Feb 20, 2026Reported quarterly or annual results70
- Nov 4, 2025Reported quarterly or annual results72
- Aug 14, 2025Reported quarterly or annual results73
- May 13, 2025Reported quarterly or annual results74
- Mar 20, 2025Reported quarterly or annual results75
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
339 filings to the SEC since October 2021: 7 annual reports, 15 quarterly reports, 107 major events, 63 insider forms, 32 large holders, 5 private raises, 110 other. The latest 20:
- Sep 1, 20268-K EDGAR
- Aug 25, 2026SCHEDULE 13G EDGAR
- Aug 20, 2026SCHEDULE 13G EDGAR
- Aug 20, 2026SCHEDULE 13G EDGAR
- Aug 14, 2026S-8 EDGAR
- Aug 14, 2026424B3 EDGAR
- Aug 14, 2026SCHEDULE 13G/A EDGAR
- Aug 14, 202610-Q EDGAR
- Aug 13, 20268-K EDGAR
- Aug 5, 20268-K EDGAR
- Jul 2, 20268-K EDGAR
- Jun 26, 2026424B3 EDGAR
- Jun 24, 2026EFFECT EDGAR
- Jun 23, 2026DEF 14A EDGAR
- Jun 12, 2026PRE 14A EDGAR
- Jun 12, 2026S-3 EDGAR
- Jun 11, 20268-K EDGAR
- Jun 9, 20268-K/A EDGAR
- Jun 9, 20268-K EDGAR
- May 7, 20268-K EDGAR
The 339 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
7 open-market trades by officers, directors and large owners since October 2021: 4 buys and 3 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 12, 2024 | FIRESTONE LAWRENCEChief Executive Officer | Buy | 39,000 | $0.27 | $10.5K | Form 4 |
| May 30, 2024 | FIRESTONE LAWRENCEChief Executive Officer | Buy | 9,000 | $1.09 | $9.8K | Form 4 |
| Jan 5, 2024 | Arno AndrewDirector | Buy | 100,000 | $0.17 | $17.0K | Form 4 |
| Jan 4, 2024 | FIRESTONE LAWRENCEChief Executive Officer | Buy | 100,000 | $0.17 | $17.0K | Form 4 |
| Aug 31, 2022 | ZERCHER MICHAELPresident and COO | Sale | 370,789 | $1.35 | $500.6K | Form 4 |
| Jun 14, 2022 | FRANZINO JOHNChief Administrative Officer | Sale | 20,324 | $1.69 | $34.3K | Form 4 |
| Dec 14, 2021 | ZERCHER MICHAELPresident and COO | Sale | 23,147 | $2.16 | $50.0K | Form 4 |
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Iroquois Capital Management, LLCSCHEDULE 13G, 4 filings Oct 23, 2024 to Aug 25, 202676
- Jonathan SchechterSCHEDULE 13G, 3 filings May 28, 2025 to Aug 20, 202677
- Joseph RedaSCHEDULE 13G, 9 filings Apr 12, 2024 to Aug 20, 202678
- Anson Funds Management LPSCHEDULE 13G/A, 7 filings Feb 14, 2024 to Aug 14, 202679
- Gregory CastaldoSCHEDULE 13G/A, 4 filings Oct 9, 2024 to Feb 13, 202680
- BlackRockSC 13G/A, 2 filings Feb 4, 2022 to Aug 9, 202281
- ETF MANAGERS GROUP, LLCSC 13G/A, 2 filings Dec 22, 2021 to May 13, 202282
- Empery Asset Management, LPSC 13G/A, 1 filing Jan 13, 202283
Money raised
Private offerings the company reported to the SEC on Form D.
- Sep 27, 2024Raised $1.2 million in a private offering of equity Form D: 7 investors so far Form D
- Apr 8, 2024Raised $4.2 million in a private offering of equity Form D: 9 investors so far Form D
- Jul 21, 2022Raised $35 million in a private offering of equity Form D: 14 investors so far Form D
- May 13, 2022Raised $58 million in a private offering of equity Form D: 64 investors so far Form D
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| Anson Funds Management LP | 34,565 | $140.0K | 0.0% | New |
| UBS Group AG | 3,208 | $13.0K | 0.0% | New |
| Barclays PLC | 164 | $664 | 0.0% | New |
| Osaic Holdings, Inc. | 8 | $32 | 0.0% | New |
| Morgan Stanley | 7 | $28 | 0.0% | New |
| Fifth Third Bancorp | 2 | $8 | 0.0% | New |
| Steward Partners Investment Advisory, LLC | 2 | $8 | 0.0% | New |
| Integrated Wealth Concepts LLC | 2 | $8 | 0.0% | New |
| Truvestments Capital LLC | 2 | $8 | 0.0% | New |
| Kilter Group LLC | 1 | $5 | 0.0% | New |
| Wells Fargo & Company/mn | 1 | $4 | 0.0% | New |
| NewEdge Advisors, LLC | 1 | $4 | 0.0% | New |
| IFP Advisors, Inc | 1 | $4 | 0.0% | New |
| Gables Capital Management Inc. | 1 | $4 | 0.0% | New |
| Caitong International Asset Management Co., Ltd | 1 | $4 | 0.0% | New |
| BlackRock, Inc. | 1 | $4 | 0.0% | New |
13F reports cover disclosed long positions in U.S. stocks only.
SEC filer profile
How 22nd Century Group, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGAR22nd Century Group, Inc.1
- CIK0001347858
- Employer ID (EIN)98-04684205
- Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; not a shell company5
- Incorporated inNevada5
- Fiscal year endsDecember 311
- Industry code (SIC)2111 Cigarettes1
- SEC reviewing officeOffice of Manufacturing, Division of Corporation Finance1
- Business address8560 Main Street, Suite 4, Williamsville, IN 142211
- Phone(716) 270-15231
- Shares outstanding713,994 as of Aug 14, 202613
- Public float$3.5M as of Jun 30, 20255
- AuditorWithumSmith+Brown, PC, Buffalo, New York PCAOB ID 100; no auditor attestation of internal control over financial reporting5
- On EDGAR sinceDec 27, 20051
- Filings912 in all: 4 (218), 8-K (212), 10-Q (54), 3 (39), SC 13G/A (34), CORRESP (30), UPLOAD (28), 424B5 (25)1
All 57 form types
424B3 (24), DEF 14A (20), EFFECT (19), 10-K (18), SC 13G (17), S-3 (16), S-1/A (11), S-8 (11), SCHEDULE 13G/A (11), D (10), 10QSB (9), PRE 14A (9), SC 13D/A (9), SCHEDULE 13G (8), 8-K/A (6), FWP (6), 4/A (5), DEFA14A (5), SC 13D (5), ARS (4), NT 10-Q (4), S-3/A (4), 10-K/A (3), 10-Q/A (3), 3/A (3), CT ORDER (3), S-8 POS (3), 10KSB (2), 8-A12B (2), PRER14A (2), S-1 (2), 1-A (1), 1-A/A (1), 25 (1), 253G3 (1), 5 (1), 8-A12G (1), CERT (1), CERTNAS (1), D/A (1), DEF 14C (1), NT 10-K (1), POS AM (1), PRE 14C (1), QUALIF (1), S-3MEF (1), SB-2 (1), SB-2/A (1), SC 14F1 (1)
- Latest filingsAnnual report (10-K) Mar 26, 2026
Quarterly report (10-Q) Aug 14, 2026
Proxy statement (DEF 14A) Jun 23, 2026
Latest 8-K (8-K) Sep 1, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Common Stock, $0.00001 par value | XXII | NASDAQ |
From the cover page of the 10-K filed Mar 26, 2026 (Section 12(b) of the Exchange Act).5
Risk factors and legal proceedings
The risks 22nd Century Group, Inc. names in Item 1A of its 10-K filed Mar 26, 2026: 33 risks under these headings, as written.5
- Risks Related to Our Business and Operations
- We have a history of losses, and we expect to incur significant expenses and continuing losses for the foreseeable future and there is substantial doubt regarding our ability to continue as a going concern.
- Our competitors generally have greater financial resources and name recognition than we do, and they may therefore develop products or other technologies similar or superior to ours, or otherwise compete more successfully than we do.
- Our competitors may develop products that are less expensive, safer or otherwise more appealing, which may diminish or eliminate the commercial success of our VLN® cigarettes or any other potential products that we may commercialize.
- Our research and development process may not develop marketable products cost-effectively or at all, which would result in loss of our investment into such process.
- The failure of our information systems to function as intended or their penetration by outside parties with the intent to corrupt them could result in business disruption, litigation and regulatory action, and loss of revenue, assets, or personal or confidential data (cybersecurity).
- Business interruptions, whether caused by natural disaster, terrorism, economic downturns, global pandemics or other events, could negatively impact our business.
- Risks Related to the Tobacco Industry
- We may be unsuccessful in our efforts to commercialize our RNC tobacco using the reduced exposure claims authorized by the FDA.
- We may be unable to renew our MRTP Application for our VLN® cigarettes.
- We have limited experience marketing and selling Modified Exposure Cigarettes and our working capital and inventory estimates based on demand expectations may be incorrect, which could harm our operating results and financial condition.
- The manufacturing and sale of tobacco products subjects us to significant government regulation and the failure to comply with such regulations could have a material adverse effect on our business and subject us to substantial fines or other regulatory actions.
The other 23 risks
- We may become subject to litigation related to cigarette smoking and/or exposure to environmental tobacco smoke, or ETS, which could severely impair our results of operations and liquidity.
- Our North Carolina manufacturing facility is integral to our tobacco business and adverse changes or developments affecting our facility may have an adverse impact on our business.
- The loss of a significant customer for whom we manufacture tobacco products could have an adverse impact on our results of operation.
- Product liability claims, product recalls, or other claims could cause us to incur losses or damage our reputation.
- Cigarettes are subject to substantial taxes. Significant increases in cigarette-related taxes have been proposed or enacted and are likely to continue to be proposed or enacted in numerous jurisdictions. These tax increases may affect the sales of our potential products and our third-parties customers’ tobacco products manufactured at our factory, which could result in decreased sales and profitability of our manufacturing business.
- Government mandated prices or taxes, production control programs, shifts in crops driven by economic conditions, climatic or adverse weather patterns may increase the cost or reduce the quality and/or supply of the tobacco and other agricultural products used to manufacture our products.
- We may distribute and sell our products outside of the U.S., which subjects us to other regulatory risks.
- We may become subject to governmental investigations on a range of matters.
- We may be unsuccessful in anticipating changes in adult consumer preferences, responding to changes in consumer purchase behavior or managing through difficult competitive and economic conditions, which could have an adverse effect on business.
- We may be unsuccessful in developing and commercializing adjacent products or processes, including innovative tobacco products that may reduce the health risks associated with certain other tobacco products and that appeal to adult tobacco consumers.
- An extended disruption at our North Carolina manufacturing facility or in service by a supplier, distributor or distribution chain service provider could have a material adverse effect on our business.
- A ban on menthol or flavored tobacco products could have a material adverse impact on our business.
- Risks Related to Intellectual Property
- We may be unable to adequately protect our intellectual property, products and potential products, and if we cannot obtain adequate protection of our intellectual property.
- The ability to commercialize our existing and potential products will depend on our ability to sell such products without infringing the patent or proprietary rights of third parties.
- Our patent applications may not result in issued patents, which may have a material adverse effect on our ability to prevent others from commercially exploiting products similar to ours.
- We license certain patent rights from third-party owners. If such owners do not properly maintain or enforce the patents underlying such licenses, our competitive position and business prospects could be harmed.
- Risks Related to Ownership of Our Common Stock
- Nasdaq may delist our common stock from trading on its exchange which could limit investors’ ability to make transactions in our common stock and subject us to additional trading restrictions.
- Our stock price may be highly volatile and could decline in value.
- Future sales of our common stock will result in dilution to our common stockholders.
- We have a significant number of outstanding securities with anti-dilution price protection.
- We do not expect to declare any dividends on our common stock in the foreseeable future.
- Our common stock may become the target of a “short squeeze.”
- Anti-takeover provisions contained in our articles of incorporation and bylaws, as well as provisions of Nevada law, could impair a takeover attempt.
Legal proceedings
See Note 11 - Commitments and Contingencies – Litigation - to our consolidated financial statements included in this Annual Report for information concerning our ongoing litigation. In addition to the lawsuits described in Note 11 to our consolidated financial statements, from time to time we may be involved in claims arising in the ordinary course of business. To our knowledge, other than the cases described in Note 11 to our consolidated financial statements, no material legal proceedings, governmental actions, investigations or claims are currently pending against us or involve us that, in the opinion of our management, could reasonably be expected to have a material adverse effect on our business and financial condition.
The opening of Item 3, Legal Proceedings.5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22SEC EDGARMichael Zercher, President
- 23SEC EDGARHenry Sicignano Iii., President
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40SEC EDGARDavid N. Keys, Board member
- 41SEC EDGARJames A. Mish, Board member
- 42SEC EDGARAndrew Arno, Board member
- 43SEC EDGARLucille S. Salhany, Board member
- 44SEC EDGARAnthony L. Johnson, Board member
- 45SEC EDGARRoger D. O'Brien, Board member
- 46SEC EDGARMichael Koganov, Board member
- 47SEC EDGARNora B. Sullivan, Board member
- 48SEC EDGARRichard M. Sanders, Board member
- 49SEC EDGARHenry Sicignano Iii., Board member
- 50SEC EDGARJoseph A. Dunn, Board member
- 51SEC EDGARJames W. Cornell, Board member
- 52SEC EDGARSteven Katz, Board member
- 53SEC EDGARJonathan Staffeldt, General counsel
- 54SEC EDGARPeter Ferola, General counsel
- 55SEC EDGARThomas L. James, General counsel
- 56
- 57
- 58
- 59SEC EDGARRegulation FD disclosure
- 60SEC EDGARResults of operations
- 61SEC EDGARShareholder vote
- 62SEC EDGAREnded a material agreement
- 63SEC EDGARShareholder vote
- 64
- 65
- 66SEC EDGARResults of operations
- 67SEC EDGAREntered a material agreement
- 68SEC EDGARResults of operations
- 69
- 70
- 71NasdaqNasdaq calendar
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83